Fenit Nirappil

Washington, D.C.

Reporter covering health care

Education: Northwestern University, BS in journalism and political science. ; American University, MSJ in journalism.

Fenit Nirappil is a reporter for the Health & Science team who covers public health, infectious diseases and LGBTQ issues. He joined the team in 2020 to cover the coronavirus pandemic. He previously spent five years on the local politics team covering D.C. government and politics, Virginia elections and government accountability. Before joining the Post, he covered the California state house for the Associated Press and Portland suburbs for The Oregonian.
Latest from Fenit Nirappil

IV fluid shortage due to hurricane prompts hospitals to postpone surgeries

Flooding of the Baxter manufacturing plant in North Carolina during Hurricane Helene prompted the FDA to declared a shortage for several IV fluid products

October 14, 2024
A man receiving fluids in an IV as he lies on a bed in the emergency room.

Harris’s doctor says she’s in ‘excellent health’ as she seeks contrast with Trump

Harris’s physician concludes that she ‘possesses the physical and mental resiliency required to successfully execute the duties of the presidency.’

October 12, 2024
Vice President Kamala Harris speaks at a rally on Thursday in Chandler, Ariz. On Saturday morning, she released her medical records.

‘This is not a cluster’: The latest on the Missouri bird flu case

Further testing could confirm whether the patient, who has since recovered, actually had bird flu despite testing positive.

October 3, 2024
Public health officials stress there is no evidence thus far of a bird flu cluster or that the virus is spreading easily among humans. (Charlie Neibergall/AP)

Why fears of human-to-human bird flu spread in Missouri are overblown

Hospital workers reported respiratory symptoms after encountering a Missouri patient with H5N1 who had not been exposed to farm animals. Officials say bird flu transmission is unlikely.

October 3, 2024
This colorized electron microscope image shows avian influenza A virus particles grown in cultured cells.

Free covid tests by mail program revived by Biden administration

People can again order four covid tests per household. The move comes ahead of an expected winter coronavirus wave.

September 26, 2024
A woman holds two boxes of at-home coronavirus test kits in Washington on Dec. 22, 2021.

CDC urges covid, flu shots, but public interest is flagging

The CDC anticipates 800,000 flu, covid and respiratory syncytial virus hospitalizations in the coming months, on par with last year.

September 26, 2024
Survey data shows few U.S. adults are concerned about respiratory viruses or interested in getting shots. (Astrid Riecken/The Washington Post)

Do you need another covid shot? Test your coronavirus knowledge.

More than four years since the coronavirus ignited a global pandemic, the virus keeps evolving. Take this quiz to find out if your covid facts are up-to-date.

September 19, 2024

Mpox vaccines arrive in Congo

The Washington Post’s essential guide to health policy news.

September 9, 2024
A man with mpox awaits treatment Wednesday at Kamituga General Hospital in South Kivu, Congo.

Coronavirus vaccines, once free, are now pricey for uninsured people

The elimination of the Bridge Access Program means some low-income Americans must pay up to $200 for an updated shot.

September 3, 2024

    New Novavax, mRNA coronavirus vaccines are approved. Here’s what to know.

    Approval of Novavax vaccine targeting JN.1 variant comes days after mRNA coronavirus vaccines from Pfizer-BioNTech and Moderna hit shelves.

    August 30, 2024
    Updated coronavirus vaccines should be available soon. The CDC recommends that everyone 6 months and older should receive one.